449 results on '"Poli Van Creveldkliniek Medisch"'
Search Results
2. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
3. Arthropathy on X-rays in 363 persons with hemophilia: long-term development, and impact of birth cohort and inhibitor status
4. A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease
5. Antiphospholipid antibody solid phase based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome
6. Patients with moderate hemophilia A and B with a severe bleeding phenotype have an increased burden of disease
7. Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease
8. Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: A systematic literature review
9. Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease
10. A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia
11. Pediatric Bone Marrow Failure: A Broad Landscape in Need of Personalized Management
12. Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada
13. Aspirin as Thromboprophylaxis in Orthopedic Surgery: A Matter of Perspective
14. High prevalence of heavy menstrual bleeding in women with rare bleeding disorders in the Netherlands: retrospective data from the RBiN study
15. One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
16. Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres
17. Psychometrics of the patient-reported outcomes measurement information system measures in hemophilia: the applicability of the pediatric item banks
18. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
19. Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
20. Heavy menstrual bleeding in adolescents: incidence, diagnostics, and management practices in primary care
21. Identifying performance-based outcome measures of physical function in people with haemophilia (IPOP)
22. Pre-operative synovial hyperaemia in haemophilia patients undergoing total knee replacement and the effects of genicular artery embolization: A retrospective cohort study
23. Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes
24. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
25. Can motor proficiency testing predict sports injuries and sports-induced bleeds in people with haemophilia?
26. Clotting factor activity levels and bleeding risk in people with haemophilia playing sports
27. HAX1-related congenital neutropenia: Long-term observation in paediatric and adult patients enrolled in the European branch of the Severe Chronic Neutropenia International Registry (SCNIR)
28. Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
29. Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study
30. Subclinical synovial proliferation in patients with severe haemophilia A: The value of ultrasound screening and biochemical markers
31. Organized Sports Activities Are Safe for Children With Sickle Cell Disease: A Pilot Intervention Study
32. Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective
33. Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: Shedding new light on an old enzyme
34. Toward responsible clinical n-of-1 strategies for rare diseases
35. Meningococcal ACWY conjugate vaccine immunogenicity in adolescents with primary or secondary immune deficiencies, a prospective observational cohort study
36. DosEmi study protocol: a phase IV, multicentre, open-label, crossover study to evaluate non-inferiority of pharmacokinetic-guided reduced dosing compared with conventional dosing of emicizumab in people with haemophilia A
37. Screening for subclinical synovial proliferation in haemophilia: A systematic review and meta-analysis comparing physical examination and ultrasound
38. Continuation of therapeutic dose heparin for critically ill patients with COVID-19
39. Meningococcal ACWY conjugate vaccine immunogenicity and safety in adolescents with juvenile idiopathic arthritis and inflammatory bowel disease: A prospective observational cohort study
40. Insights in the Prothrombotic Changes after Implantation of a Left Ventricular Assist Device in Patients with End-Stage Heart Failure: A Longitudinal Observational Study
41. The Pyruvate Kinase Deficiency Global Longitudinal (Peak) Registry: rationale and study design
42. No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients
43. Structural changes after ankle joint distraction in haemophilic arthropathy: an explorative study investigating biochemical markers and 3D joint space width
44. Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
45. The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
46. Early-onset reduced bone mineral density in patients with pyruvate kinase deficiency
47. Functional decline in persons with haemophilia and factors associated with deterioration
48. Blood coagulation and beyond: Position paper from the Fourth Maastricht Consensus Conference on Thrombosis
49. Acquired blood platelet disorder in patients with end-stage heart failure after implantation of a continuous centrifugal-flow left ventricular assist device: A prospective cohort study
50. Aptamers targeting von willebrand factor: What and why?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.